Literature DB >> 33394674

Importance of rigorous implementation science studies to scale-up evidence-based interventions to end the HIV epidemic in the United States.

Dvora L Joseph Davey1,2, Laing de Villiers3,4, Emily Evens5.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33394674      PMCID： PMC8358662          DOI： 10.1097/QAD.0000000000002696

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Ending the HIV Epidemic: A Plan for the United States.

Authors:  Anthony S Fauci; Robert R Redfield; George Sigounas; Michael D Weahkee; Brett P Giroir
Journal:  JAMA       Date:  2019-03-05       Impact factor: 56.272

2.  Ending the HIV Epidemic in the United States: Closing the Implementation Gaps.

Authors:  Hilary D Marston; Carl W Dieffenbach; Anthony S Fauci
Journal:  Ann Intern Med       Date:  2018-08-21       Impact factor: 25.391

3.  A systematic review of early adoption of implementation science for HIV prevention or treatment in the United States.

Authors:  Sylvia Shangani; Nidhi Bhaskar; Natasha Richmond; Don Operario; Jacob J van den Berg
Journal:  AIDS       Date:  2021-02-02       Impact factor: 4.177

4.  An introduction to implementation science for the non-specialist.

Authors:  Mark S Bauer; Laura Damschroder; Hildi Hagedorn; Jeffrey Smith; Amy M Kilbourne
Journal:  BMC Psychol       Date:  2015-09-16

5.  Making sense of implementation theories, models and frameworks.

Authors:  Per Nilsen
Journal:  Implement Sci       Date:  2015-04-21       Impact factor: 7.327
  5 in total
  1 in total

1.  Development of an Implementation Facilitation Strategy to Link Mental Health Screening and eHealth Intervention for Clients in Ryan White-Funded Clinics in Chicago.

Authors:  Tammy K Stump; Kristen Ethier; Lisa R Hirschhorn; Andrea Dakin; Nora Bouacha; Angela Freeman; Jacqueline Bannon; Walter Gómez; Judith T Moskowitz; Alida Bouris
Journal:  J Acquir Immune Defic Syndr       Date:  2022-07-01       Impact factor: 3.771
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.